Article R2141-1-9 of the French Public Health Code
The Director General of the Agence de la biomédecine may at any time suspend or withdraw authorisation for the implementation of a technique if the conditions laid down in this section are no longer satisfied or for any public health reason. Suspension for a period of more than three months and withdrawal are decided after obtaining the opinion of the Agency’s Steering Committee. Reasons must be given for the decision…